Insight Molecular Diagnostics (IMDX) Earnings Analysis
Insight Molecular Diagnostics (IMDX) next reports earnings on 2026-08-10, consensus EPS -0.24 USD. Last quarter (2026-03-26) it missed with EPS -0.27 USD vs -0.2375 USD est (-13.7%). It has beaten estimates in 2/6 recent quarters (33%). Trailing P/E -3.30.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does IMDX next report earnings?
| Next earnings date | 2026-08-10 |
|---|---|
| Consensus EPS estimate | -0.24 USD |
| Revenue estimate | 0.00B |
IMDX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-26 | -0.27 USD | -0.2375 USD | -13.7% | Miss |
| 2025-11-10 | -0.34 USD | -0.24 USD | -41.7% | Miss |
| 2025-08-11 | -0.3 USD | -0.23 USD | -30.4% | Miss |
| 2025-05-12 | -0.26 USD | -0.24 USD | -8.3% | Miss |
| 2025-03-24 | 0.48 USD | -0.43 USD | +211.6% | Beat |
| 2024-08-08 | -0.36 USD | -0.56 USD | +35.7% | Beat |
Beat rate: 2/6 (33%) over reported quarters with consensus data.
IMDX valuation and analyst view
| Trailing P/E | -3.30 |
|---|---|
| Trailing EPS | -1.38593 USD |
| Price / book | -16.11 |
| Dividend yield | 0.00% |
| Market cap | 0.14B |
| Analyst consensus | Buy (7 buy / 4 hold / 0 sell) |
| Avg price target | 10.5 USD |
Related research pages
Frequently asked questions
When is Insight Molecular Diagnostics (IMDX)'s next earnings date?
Insight Molecular Diagnostics is next scheduled to report on 2026-08-10, with a consensus EPS estimate of -0.24 USD and revenue estimate of 0.00B.
Did IMDX beat earnings last quarter?
In its 2026-03-26 report, IMDX posted EPS of -0.27 USD versus a -0.2375 USD estimate — a miss of 13.7%.
What is IMDX's earnings track record?
Over the last 6 reported quarters with consensus data, IMDX beat estimates 2 times (33%).
What is IMDX's current P/E ratio and EPS?
IMDX trades at a trailing P/E of -3.30 on trailing EPS of -1.3859323850632985 USD.
What do analysts rate IMDX?
Analyst consensus is "Buy" across 11 ratings (0 strong buy, 7 buy, 4 hold, 0 sell, 0 strong sell). Average 12-month price target: 10.5 USD.